SECOND-LINE HELICOBACTER PYLORI ERADICATION THERAPY AFTER FAILURE OF NON-BISMUTH QUADRUPLE "CONCOMITANT" TREATMENT

被引：0
|
作者：
Kim, S. [1 ]
Choe, J. [1 ]
Jung, S. [1 ]
Park, J. [1 ]
Chun, H. [1 ]
Lee, S. [1 ]
机构：
[1] Korea Univ, Seoul, South Korea
来源：
HELICOBACTER | 2015年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P02.06
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [11] SECOND-LINE RESCUE THERAPY WITH LEVOFLOXACIN AND BISMUTH AFTER FAILURE OF A HELICOBACTER PYLORI ERADICATION TREATMENT
    Gisbert, J. P.
    Solis-Munoz, P.
    Romano, M.
    Gravina, A.
    Lucendo, A.
    Molina-Infante, J.
    Velayos, B.
    Herranz, M.
    Barrio, J.
    Modolell, I.
    Gomez, J.
    Del Castillo, F.
    Dominguez, J. L.
    Federico, A.
    Martorano, M.
    Angueira, T.
    Fernandez-Salazar, L.
    Miranda, A.
    Marin, A. C.
    McNicholl, A. G.
    [J]. HELICOBACTER, 2014, 19 : 135 - 135
  • [12] Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection
    Gisbert, Javier P.
    Molina-Infante, Javier
    Marin, Alicia C.
    Vinagre, Gemma
    Barrio, Jesus
    McNicholl, Adrian Gerald
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (06) : 652 - 656
  • [13] Second-Line Rescue Triple Therapy With Levofloxacin After Failure of Non-Bismuth Quadruple "Sequential" or "Concomitant" Treatment to Eradicate H. pylori Infection
    Gisbert, Javier P.
    Molina-Infante, Javier
    Marin, Alicia C.
    Rodriguez, Gema Vinagre
    Barrio, Jesus
    McNicholl, Adrian G.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S334 - S334
  • [14] Second-Line Rescue Triple Therapy With Levofloxacin After Failure of Non-Bismuth Quadruple "Sequential" or "Concomitant" Treatment to Eradicate H-pylori Infection
    Gisbert, Javier P.
    Molina-Infante, Javier
    Marin, Alicia C.
    Rodriguez, Gema Vinagre
    Barrio, Jesus
    McNicholl, Adrian G.
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S394 - S394
  • [15] Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies
    Graham, David Y.
    Dore, Maria Pina
    Lu, Hong
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (09) : 679 - 687
  • [16] NON-BISMUTH QUADRUPLE (CONCOMITANT) THERAPY FOR ERADICATION OF HELICOBATER PYLORI: A SYSTEMATIC REVIEW
    Gisbert, J. P.
    Calvet, X.
    [J]. HELICOBACTER, 2011, 16 : 131 - 131
  • [17] Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
    Gisbert, J. P.
    Calvet, X.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (06) : 604 - 617
  • [18] Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication:A randomized study in Japan
    Ayako Yanai
    Kei Sakamoto
    Masao Akanuma
    Keiji Ogura
    Shin Maeda
    [J]. World Journal of Gastrointestinal Pharmacology and Therapeutics, 2012, (01) : 1 - 6
  • [19] Bismuth containing quadruple therapy for second line Helicobacter pylori eradication
    Lee, M.
    Lee, B.
    Kim, G.
    Park, E.
    Jeon, H.
    Song, G.
    [J]. HELICOBACTER, 2017, 22
  • [20] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Kim, Hae Koo
    Dal Lee, Young
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (06) : 1059 - 1066
12345